Akorn Pharmaceuticals is exiting the market and closing all US facilities immediately. According to the current market intelligence, there will be no additional production of Akorn products at its manufacturing plants while the company is shut down. Product that is already in the supply chain will continue to be available until inventory is depleted.
Read the conclusions, recommendations and mitigation strategies.